Zhitong Finance App News, Lingkang Pharmaceutical (603669.SH) announced that Hainan Lingkang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, participated in the bidding process led by Henan Province to carry out centralized volume procurement work for 34 drugs. According to the “34 Drugs Interprovincial Alliance Procurement Notice (8)” issued by the “34 Drugs Interprovincial Alliance Procurement Office” on August 11, 2026 on the Henan Pharmaceutical Centralized Procurement Platform, the subsidiary's product was selected for this procurement.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.